Status:
UNKNOWN
COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)
Lead Sponsor:
Azienda Ospedaliera San Paolo
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The aims of this study is to define the genetic bases of COVID-19 related disease heterogeneity in frail population, to carry out a retrospective study on individuals w/wo symptoms to verify the relia...
Eligibility Criteria
Inclusion
- adult patients (\> 18 years old)
Exclusion
- inability to understand and want;
- mentally incapacitated.
Key Trial Info
Start Date :
March 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04367402
Start Date
March 30 2020
End Date
September 1 2020
Last Update
April 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AO San Paolo
Milan, IT, Italy, 20142